I’m proud to be starting this alongside exceptional people with @oskarth and @_rymnc . In additional to phenomenal backers such as @BitMNR , @Sharplink , @snzholding and @ethereumJoseph . Finance is evolving. Privacy is the difference between Ethereum holding billions in assets today and running trillions in financial activity tomorrow. This is only the beginning.

Fortum is seeking Swedish state aid for a new 1.2–3.4 GW nuclear plant at Oskarshamn. Sweden wants two new reactors by 2035 and 10 by 2045, backed by state loans and power-price guarantees. #NuclearEnergy# #Sweden# #EnergySecurity#

As a young socialist, Hayek read Ludwig von Mises’ 1920 paper “Economic Calculation in the Socialist Commonwealth.” Mises showed that socialist central planning isn’t merely inefficient, it’s impossible. Without private property and genuine market prices, planners lack any rational way to allocate scarce resources or determine real costs and needs. Even Oskar Lange, a leading socialist in the calculation debate, effectively conceded the point. While he promoted “market socialism” with trial-and-error pricing by a central board, real-world socialist planners in Eastern Europe quietly relied on world capitalist market prices as a guide. Without external free-market price signals, pure socialism would be economically blind and coordination would collapse. Mises went further, arguing that interventionism, the “middle way” of government meddling, is inherently unstable. Each intervention creates problems that invite more interventions, eventually leading to full socialization. Price controls cause shortages, subsidies distort production, and the cycle continues until the economy is fully planned. The lesson is clear. Rational economics requires genuine market prices emerging from voluntary exchange and private property. Half-measures don’t stabilize the system. They accelerate the drift into central planning. The Austrian School understood this decades before the collapse of the Soviet bloc proved it in practice.

Oscar Health $OSCR price target raised to $49 from $39 at Barclays Barclays analyst Andrew Mok raised the firm's price target on Oscar Health to $49 from $39 and keeps an Overweight rating on the shares following the investor day. Oscar outlined a "credible path" to over $4 of earnings per share by 2029 and implied 2027 earnings over $3.00 versus the $1.92 Street estimate, the analyst tells investors in a research note. Barclays sees "significant growth ahead" for Oscar.

Oscar Isaac says Carey Mulligan is the best actor he’s ever worked with: “Nobody compares to her in my book, She’s incredibly funny, deep, and soulful. She’s both intuitive and also incredibly precise. It’s a real magic trick with her.”